Carroll E Cross

Title: Carroll E Cross: Innovator in Fusion Protein Technology

Introduction

Carroll E Cross is a notable inventor based in Davis, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins aimed at treating inflammatory diseases. His innovative work has the potential to impact the treatment of various inflammatory conditions.

Latest Patents

Carroll E Cross holds a patent for "Fusion proteins for treating inflammatory diseases." This invention provides plant-made elafin-Fc fusion proteins that are designed to treat inflammatory lung diseases. The fusion proteins include point mutations that enhance their properties, such as increased resistance to oxidation and cleavage, as well as an extended half-life. Additionally, the patent encompasses polynucleotides encoding the fusion proteins, recombinant cells, expression vectors, and transgenic plants that contain the coding sequences for these fusion proteins. The invention also outlines methods for producing these fusion proteins.

Career Highlights

Carroll E Cross is affiliated with the University of California, where he continues to advance research in biotechnology. His work is characterized by a commitment to developing innovative solutions for complex medical challenges.

Collaborations

Carroll has collaborated with esteemed colleagues, including Karen A McDonald and Kalimuthu Karuppanan, to further enhance the impact of his research and innovations.

Conclusion

Carroll E Cross is a pioneering inventor whose work in fusion protein technology holds promise for the treatment of inflammatory diseases. His contributions to biotechnology exemplify the importance of innovation in addressing health challenges.